Maravai Lifesciences Holdings (MRVI) Revenue (2020 - 2026)

Maravai Lifesciences Holdings' Revenue history runs 7 years deep, the most recent figure standing at $65.8 million for Q1 2026.

• In Q1 2026, Revenue rose 40.53% year-over-year to $65.8 million; the TTM figure through Mar 2026 stood at $204.7 million (down 15.35% YoY), while the FY2025 annual figure was $185.7 million, down 28.34% from the prior year.
• Revenue was $65.8 million for Q1 2026 at Maravai Lifesciences Holdings, up from $49.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $244.3 million in Q1 2022 to a low of $41.6 million in Q3 2025.
• Historically, Revenue has averaged $99.0 million across 5 years, with a median of $68.9 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue jumped 64.83% in 2022, then slumped 71.61% in 2023.
• A 5-year view of Revenue shows it stood at $204.7 million in 2022, then slumped by 63.78% to $74.1 million in 2023, then decreased by 23.72% to $56.6 million in 2024, then retreated by 11.83% to $49.9 million in 2025, then surged by 32.03% to $65.8 million in 2026.
• The last three Revenue figures came in at $65.8 million (Q1 2026), $49.9 million (Q4 2025), and $41.6 million (Q3 2025), per Business Quant data.